Who Should Attend the 9th International Neoantigen Summit?
As neoantigen therapeutics reach a critical inflection point, the need to connect, validate approaches, and accelerate clinical progress has never been greater. The 9th International Neoantigen Summit brings together the full ecosystem of experts working to translate neoantigen science into meaningful clinical outcomes.
Whether you are advancing discovery, refining translational strategy, or navigating clinical development, this is the one meeting designed to support every stage of your pipeline.
Built for the Entire Neoantigen Ecosystem
No matter where you sit within the development lifecycle, the summit is structured to deliver relevant insights and connections.
Discovery & Antigen Identification Experts
For teams working on neoantigen identification and validation, the summit explores how bioinformatics and AI are improving target selection and accelerating early-stage workflows.
Preclinical & Translational Scientists
If you’re bridging discovery and clinical development, sessions focus on optimising preclinical strategy and overcoming bottlenecks in trial setup.
Clinical DevelopmentLeaders
For clinical leaders, the summit provides access to emerging data across both personalised and off-the-shelf neoantigen approaches.
One Focus, One Community
Unlike broader oncology events, this meeting is dedicated solely to neoantigen therapies. That means every session, discussion, and connection is directly relevant to your work.
If your goal is to move your pipeline forward faster, this is where your team needs to be.